Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.
Zhou M, Wang S, Wan N, Yuan S, Hu X, Zhou W, Qing B, Liu M, Sun W, Fan P, Wang J, Cao H, Xu H, Dai B, Tang P, Qian L, Zhao X, Xiao J, Zhou H, Hu J, Ding L, Tripodi D, Zdenkowski N, O'Keefe TJ, Sanchez AM, Chen L, Zhang P, Xu F.
Zhou M, et al. Among authors: xu f, xu h.
Ann Transl Med. 2022 Dec;10(24):1387. doi: 10.21037/atm-22-6054.
Ann Transl Med. 2022.
PMID: 36660637
Free PMC article.